Antibody engineering & therapeutics, the annual meeting of the antibody society December 7–10, 2015, San Diego, CA, USA-Reference-Cited by-同舟云学术

Antibody engineering & therapeutics, the annual meeting of the antibody society December 7–10, 2015, San Diego, CA, USA

Published:2016-02-24 Issue:3 Volume:8 Page:617-652
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Pauthner Matthias,Yeung Jenny,Ullman Chris,Bakker Joost,Wurch Thierry,Reichert Janice M.,Lund-Johansen Fridtjof,Bradbury Andrew R.M.,Carter Paul J.,Melis Joost P.M.

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/19420862.2016.1153211

Reference50 articles.

1. Suppression of Fcγ-Receptor-Mediated Antibody Effector Function during Persistent Viral Infection

2. Complement Is Activated by IgG Hexamers Assembled at the Cell Surface

3. A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface

4. Complement in therapy and disease

5. Immunogenicity of protein therapeutics: The key causes, consequences and challenges

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical landscape of LAG-3-targeted therapy;Immuno-Oncology and Technology;2022-06

2. Nanomedicine-mediated optimization of immunotherapeutic approaches in cervical cancer;Nanomedicine;2021-06

3. Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck;International Journal of Biological Sciences;2020

4. Clinical cancer nanomedicine;Nano Today;2019-04

5. The Plasticity of Th17 Cells in the Pathogenesis of Rheumatoid Arthritis;Journal of Clinical Medicine;2017-07-10